This study established the immunomodulating effect of the oral administration of a formula containing Lactobacillus strains, arabinogalactan, and colostrum towards increasing the number of activated NK cells in the peripheral blood as well as decreasing IL-6 and IFN-γ levels in the fecal samples, both in healthy individuals and patients with IBS. This evidence concerns the gene IFNG and irritable bowel syndrome.